(Q34549921)

3 August 2017

title

Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Bowcock SJ

1

1 reference

3 August 2017

Stockdale AD

2

1 reference

3 August 2017

Bolton JA

3

1 reference

3 August 2017

Kang AA

4

1 reference

3 August 2017

Retsas S

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 1984

1 reference

3 August 2017

1 reference

3 August 2017

volume

288

1 reference

3 August 2017

issue

6434

1 reference

3 August 2017

page(s)

1879

1 reference

The two-period cross-over clinical trial

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1441757

PubMed Central

reference URL

Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy

7 July 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/6428589

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://pubmed.ncbi.nlm.nih.gov/6428589

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.288.6434.1879

0 references

PMC publication ID

1441757

1 reference

3 August 2017

1 reference